Enfuvirtide effects on human erythrocytes and lymphocytes functional properties

Journal of Peptide Science : an Official Publication of the European Peptide Society
Catarina R VieiraNuno C Santos

Abstract

Enfuvirtide (T-20) is the first inhibitor of human Immunodeficiency Virus type-1 (HIV-1) entrance on a target cell approved for clinical use. Recent studies indicated that its action mechanism involves the interaction with the membrane surface, increasing the concentration in the site of action. In the present study, the in vitro interaction between enfuvirtide and blood cells of healthy human donors, namely erythrocytes and lymphocytes, and the peptide effect on plasma and lymphocyte suspensions supernatant ions were evaluated, in order to better characterize the action of this peptide. Enfuvirtide causes a decrease in the concentration of hemoglobin and in the percentages of methemoglobin and carboxyhemoglobin, together with increased values of P50, pCO2, and [HCO3-], and significant decreases of pO2 and pH, in blood plasma. The supernatants of lymphocyte suspensions derived from blood incubated with enfuvirtide presented a decrease in pH and [HCO3-]. Fluorescence anisotropy measurements of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-(4-(trimethylamino)-phenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), used to assess erythrocyte and lymphocyte membrane fluidity, did not yield enfuvirtide-induced changes (an effect could be expected ...Continue Reading

References

Sep 1, 1980·The Journal of Clinical Investigation·N MohandasS B Shohet
Jul 6, 1981·Biochimica Et Biophysica Acta·K Araki, J M Rifkind
Feb 1, 1982·British Journal of Haematology·J G SzelényiS R Hollán
Aug 1, 1996·The European Respiratory Journal·M DrentM van Dieijen-Visser
Apr 18, 1998·Nature Structural Biology·R A FurutaC D Weiss
Jun 18, 1998·Cell·D C Chan, P S Kim
Oct 31, 1998·BMJ : British Medical Journal·A J Williams
Sep 22, 1999·European Journal of Biochemistry·D GrisaruH Soreq
Nov 30, 2000·Critical Care : the Official Journal of the Critical Care Forum·J A Kellum
Mar 10, 2001·AIDS Research and Human Retroviruses·P W MobleyL M Gordon
Apr 12, 2002·Current Pharmaceutical Design·Shibo JiangAsim K Debnath
Sep 25, 2002·Clinics in Laboratory Medicine·Linda D Starr-Spires, Ronald G Collman
Mar 13, 2003·Molecular Biology of the Cell·Ruben M MarkosyanGrigory B Melikyan
Mar 15, 2003·The New England Journal of Medicine·Jacob P LalezariUNKNOWN TORO 1 Study Group
May 30, 2003·The New England Journal of Medicine·Adriano LazzarinUNKNOWN TORO 2 Study Group
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Nov 25, 2003·Seminars in Thrombosis and Hemostasis·Oguz K Baskurt, Herbert J Meiselman
Nov 13, 2004·Journal of the American Chemical Society·A Salomé VeigaMiguel A R B Castanho
Sep 23, 2006·AIDS Research and Human Retroviruses·J Martins-SilvaCarlota Saldanha
Jan 29, 2008·Recent Patents on Anti-infective Drug Discovery·Ana Salomé VeigaMiguel A R B Castanho

❮ Previous
Next ❯

Citations

Mar 20, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Miguel A R B Castanho, Margitta Dathe
Feb 27, 2016·AIDS·Huihui ChongYuxian He

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.